Engineering of conserved residues near antibody heavy chain complementary determining region 3 (HCDR3) improves both affinity and stability
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, ISSN: 1570-9639, Vol: 1871, Issue: 4, Page: 140915
2023
- 1Citations
- 5Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
Izmir Biomedicine and Genome Center Reports Findings in Immunoglobulins [Engineering of conserved residues near antibody heavy chain complementary determining region 3 (HCDR3) improves both affinity and stability]
2023 MAY 05 (NewsRx) -- By a News Reporter-Staff News Editor at Engineering Daily News -- New research on Immunology - Immunoglobulins is the subject
Article Description
Affinity and stability are crucial parameters in antibody development and engineering approaches. Although improvement in both metrics is desirable, trade-offs are almost unavoidable. Heavy chain complementarity determining region 3 (HCDR3) is the best-known region for antibody affinity but its impact on stability is often neglected. Here, we present a mutagenesis study of conserved residues near HCDR3 to elicit the role of this region in the affinity-stability trade-off. These key residues are positioned around the conserved salt bridge between V H -K94 and V H -D101 which is crucial for HCDR3 integrity. We show that the additional salt bridge at the stem of HCDR3 (V H -K94:V H -D101:V H -D102) has an extensive impact on this loop's conformation, therefore simultaneous improvement in both affinity and stability. We find that the disruption of π-π stacking near HCDR3 (V H - Y100E:V L -Y49) at the V H -V L interface cause an irrecoverable loss in stability even if it improves the affinity. Molecular simulations of putative rescue mutants exhibit complex and often non-additive effects. We confirm that our experimental measurements agree with the molecular dynamic simulations providing detailed insights for the spatial orientation of HCDR3. V H -V102 right next to HCDR3 salt bridge might be an ideal candidate to overcome affinity-stability trade-off.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1570963923000298; http://dx.doi.org/10.1016/j.bbapap.2023.140915; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85152886694&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37059314; https://linkinghub.elsevier.com/retrieve/pii/S1570963923000298; https://dx.doi.org/10.1016/j.bbapap.2023.140915
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know